Key result
Gadolinium-enhanced CMR reveals midwall fibrosis in a patient with chemotoxic cardiomyopathy.
Population
1 patient with chemotoxic cardiomyopathy
Design
Case_report
Authors
Loading...
May identify midwall fibrosis via CMR in chemotoxic cardiomyopathy; hypothesis-generating and should not yet change practice.
Gadolinium-enhanced CMR can identify midwall fibrosis or myocardial cell loss in patients with chemotoxic cardiomyopathy.
Catalano et al. (2007) studied this question. Gadolinium-enhanced cardiac magnetic resonance revealed intramyocardial midwall linear delayed hyperenhancement indicating fibrosis in a patient with chemotoxic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: